Clinical Proteomic Technologies Initiative for Cancer (CPTI)

Established: 2005

The overall objective of the five-year, $104 million Clinical Proteomic Technologies Initiative for Cancer (CPTI) is to build the foundation of technologies, data, reagents and reference materials, analysis systems, and infrastructure needed to systematically advance our understanding of protein biology in cancer and accelerate discovery research and clinical applications.

The goals of the Clinical Proteomic Technologies Initiative for Cancer are to:

• Enhance technical abilities to identify and measure proteins accurately and reproducibly in biological systems
• Advance proteomics as a reliable, quantitative field that can accelerate discovery and translational research

For more information about the Clinical Proteomic Technologies Initiative for Cancer, please visit http://proteomics.cancer.gov.

For more information about NCI’s funding of proteomics, click here.